Skip to main content
profile image
Selected Works of Gerald Sokol, MD, MSc, FCP
Article
Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer
Investigational New Drugs (2021)
  • Benjamin A. Gartrell, Albert Einstein College of Medicine
  • Mack Roach, University of California, San Francisco
  • Avi Retter, NY Cancer and Blood Specialist, East Setauket, USA
  • Gerald H. Sokol, Division of Clinical Pharmacology, Uniform Services University of the Health Sciences, Bethesda, USA
  • Giuseppe Del Priore, TYME Inc, New York, USA
  • Howard I. Scher, Cornell University
  • Howard I. Scher, Memorial Sloan Kettering Cancer Center
Link
Disciplines
Publication Date
April 1, 2021
DOI
10.1007/S10637-020-00993-4
Citation Information
Benjamin A. Gartrell, Mack Roach, Avi Retter, Gerald H. Sokol, et al.. "Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer" Investigational New Drugs Vol. 39 Iss. 2 (2021) p. 499 - 508
Available at: http://works.bepress.com/gerald-sokol/1/